Jean-Marie Michot

15
Documents

Publications

Publications

Image document

Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA

Amira Marouf , Sammara Chaubard , Raphaël Liévin , Jean-Marie Michot , Nicolas Molinari et al.
HemaSphere, 2025, 9 (1), pp.e70081. ⟨10.1002/hem3.70081⟩
Article dans une revue hal-04926143 v1

Drug‐induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome

Marion Plaçais , Ariane Laparra , Alexandre Thibault Jacques Maria , Nora Kramkimel , Audrey Perret et al.
American Journal of Hematology, 2024, 99 (7), pp.1427-1430. ⟨10.1002/ajh.27339⟩
Article dans une revue hal-04960905 v1
Image document

Impact of Clonal Hematopoiesis–Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial

Julieta Rodriguez , Capucine Baldini , Arnaud Bayle , Arnaud Pages , François Xavier Danlos et al.
JCO precision oncology, 2024, 8, pp.e2300631. ⟨10.1200/PO.23.00631⟩
Article dans une revue inserm-04981546 v1
Image document

Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma

Yuta Ito , Amira Marouf , Yasunori Kogure , Junji Koya , Raphaël Liévin et al.
Cancer Research, 2024, 84 (13), pp.2181-2201. ⟨10.1158/0008-5472.CAN-24-0132⟩
Article dans une revue inserm-04773439 v1
Image document

Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series

Cyrille Coustal , Juliette Vanoverschelde , Xavier Quantin , Candice Lesage , Jean-Marie Michot et al.
Journal for Immunotherapy of Cancer, 2023, 11 (5), pp.e004792. ⟨10.1136/jitc-2022-004792⟩
Article dans une revue hal-04116183 v1
Image document

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA

Amira Marouf , Sammara Chaubard , J.M. Michot , Julien Rossignol , Camille Golfier et al.
HemaSphere, 2023, Hemasphere, 7 (S3), pp.e41118bf. ⟨10.1097/01.hs9.0000967816.41118.bf⟩
Article dans une revue hal-04406218 v1

Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial

Vincent Camus , Aurélien Belot , Lucie Oberic , David Sibon , Hervé Ghesquières et al.
Blood Advances, 2022, 6 (24), pp.6169-6179. ⟨10.1182/bloodadvances.2022007609⟩
Article dans une revue hal-04946564 v1
Image document

Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review

C. Corti , G. Antonarelli , F. Scotté , J.P. Spano , J. Barrière et al.
Annals of Oncology, 2022, 33 (2), pp.158-168. ⟨10.1016/j.annonc.2021.10.014⟩
Article dans une revue hal-03955867 v1
Image document

Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study

Charlotte Cabanié , Samy Ammari , Sophie Hans , Cedric Pobel , Ariane Laparra et al.
European Journal of Cancer, 2021, 156, pp.46-59. ⟨10.1016/j.ejca.2021.07.015⟩
Article dans une revue hal-04532592 v1
Image document

Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit

Adrien Joseph , Audrey Simonaggio , Annabelle Stoclin , Antoine Vieillard-Baron , Guillaume Geri et al.
Annals of Intensive Care, 2020, 10 (1), ⟨10.1186/s13613-020-00761-w⟩
Article dans une revue hal-02996544 v1

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Guillaume Manson , Alexandre Thibault Jacques Maria , Florence Poizeau , François-Xavier Danlos , Marie Kostine et al.
Journal for Immunotherapy of Cancer, 2019, 7 (1), ⟨10.1186/s40425-019-0821-8⟩
Article dans une revue hal-02530293 v1

Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1

Ahmed Mekki , Laurent Dercle , Philip Lichtenstein , Aurélien Marabelle , Jean-Marie Michot et al.
European Journal of Cancer, 2018, 96, pp.91-104. ⟨10.1016/j.ejca.2018.03.006⟩
Article dans une revue hal-04534637 v1

Organisational factors influencing early clinical trials enrollment: Gustave Roussy experience

Sylvain Besle , Emilien Schultz , Antoine Hollebecque , Andreea Varga , Capucine Baldini et al.
European Journal of Cancer, 2018, 98 (2), pp.17-22. ⟨10.1016/j.ejca.2018.04.019⟩
Article dans une revue hal-04508716 v1
Image document

Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease

Jean-Marie Michot , Françoise Driss , Corinne Guitton , Julia Moh Klaren , François Lefebvre et al.
Transfusion, 2015, 55 (2), pp.357-363. ⟨10.1111/trf.12875⟩
Article dans une revue istex inserm-01995062 v1

Efficacy of anti‐PD1 therapy in relapsed or refractory NK/T cell lymphoma: a matched cohort analysis from the LYSA

A. Marouf , S. Chaubard , J. Michot , R. Liévin , J. Rossignol et al.
17th International Conference on Malignant Lymphoma,, Jun 2023, Lugano, Switzerland. pp.502-503, ⟨10.1002/hon.3164_369⟩
Communication dans un congrès hal-04406191 v1